BC
CVET

Barnett & Company’s Covetrus, Inc. Common Stock CVET Stock Holding History

Barnett & Company’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,188
Closed -$197K – 310
2019
Q1 		$197K Buy
+6,188
New +$220K 0.11% 101

Other funds holding CVET

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Barnett & Company's CVET Position: Q2 2019 in Review

Barnett & Company sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2019, closing a stake of 6,188 shares — an estimated $197K sold.

Barnett & Company first reported a position in CVET in Q1 2019 and held it in 1 quarter. The position peaked at $197K in Q1 2019. 321 funds tracked by Wall St. Rank hold CVET as of Q2 2019.

  • Barnett & Company reported no remaining Covetrus, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Barnett & Company sold 6,188 Covetrus, Inc. Common Stock shares in Q2 2019, an estimated $197K.
  • Barnett & Company first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Barnett & Company's Covetrus, Inc. Common Stock position peaked at $197K in Q1 2019.
  • 321 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2019.

Based on Barnett & Company's 13F filing for Q2 2019, filed 30 Jul 2019.